International Research Journal of Engineering and Technology (IRJET)
e-ISSN: 2395-0056
Volume: 12 Issue: 02 | Feb 2025
p-ISSN: 2395-0072
www.irjet.net
Quality by Design [QbD] Approach in Pharmaceutical Development: Principles, Implementation and Challenges Uday A.Satpute1, Manik P.Satwadhar2, Shifa Sayyad3, Shubham Mhaske4 1,2,3Student, Pravara Rural College of Pharmacy, Pravaranagar, Maharashtra, India,413736
4Assistant Professor, Department of Quality Assurance, Pravara Rural College of Pharmacy, Pravaranagar,
Maharashtra, India,413736 ---------------------------------------------------------------------***---------------------------------------------------------------------
Abstract - Pharmaceutical development has been completely transformed by Quality by Design (QbD), which integrates quality into the product from the very beginning rather than depending solely on end-product testing. The main ideas of Quality-Based Design (QbD), such as design space, Critical Process Parameters (CPPs), and Critical Quality Attributes (CQAs), are discussed in this study along with the advantages and disadvantages of using QbD to pharmaceutical production. The analysis also looks at how QbD lowers variability, increases overall product quality, and improves regulatory compliance. Widespread adoption is hampered by early costs, regulatory obstacles, and the complexity of data administration, despite its many benefits. This study emphasizes the significance of innovation, risk management, and continuous improvement within the QbD framework as pharmaceutical businesses move more and more toward QbD.
Key Words: Quality by Design (QbD), Pharmaceutical Development, Critical Quality Attributes (CQAs), Critical
Process Parameters (CPPs), Design Space, Risk Management, Process Analytical Technology (PAT), Regulatory Compliance, Pharmaceutical Quality System, ICH Guidelines, Quality Risk Management
1. INTRODUCTION Pharmaceutical quality control has historically depended on a number of end-product testing techniques to make sure drugs fulfil specified requirements for safety, identification, potency, and purity. Instead of anticipating problems early on in the development process and proactively addressing them, this method frequently concentrates on reactive measures, such as reviewing final goods. However, a move toward more comprehensive quality assurance systems has become necessary due to the complexity of contemporary drug research, growing regulatory scrutiny, and the need for increased efficiency. In order to make sure that quality is ingrained in the process from the beginning rather than being tested at the conclusion, Quality by Design, or QbD, was presented as a proactive framework during the product design and development phases. In the current pharmaceutical landscape, where there is an increasing desire for safer, more effective medications, the adoption of QbD is particularly crucial. QbD lowers variability, promotes innovation, and improves outcome predictability by placing a high priority on a methodical understanding of the product and its production process. It promotes the incorporation of risk-based and scientific methodologies into drug development, which eventually results in more effective medicinal products and efficient regulatory procedures. With the market shifting toward complicated biologics and personalized medicine, QbD provides a strong foundation for handling the inherent uncertainties of these cutting-edge treatments. This paper aims to provide an overview of Quality by Design, clarify its advantages and disadvantages, and investigate potential future applications for the pharmaceutical sector. This review seeks to give insights for researchers, practitioners, and regulatory agencies looking to improve pharmaceutical quality and innovation by looking at how QbD can be adopted successfully and identifying potential roadblocks.
1.1 Quality by Design (QbD): The Quality by Design (QbD) methodology is a methodical approach to pharmaceutical development that prioritizes the design of quality into products at the outset, as opposed to depending solely on end-product testing. To guarantee constant quality, the basic concept is to comprehend the relationship between the raw materials, production procedures, and the finished product. Defining quality attributes, determining essential parameters, and using risk management to reduce variability are all part of QbD.
© 2025, IRJET
|
Impact Factor value: 8.315
|
ISO 9001:2008 Certified Journal
|
Page 83